Stocks and Investing Stocks and Investing
Tue, August 23, 2022

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Increased Target to $210 on, Aug 23rd, 2022


Published on 2024-10-27 22:47:14 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $180 to $210 on, Aug 23rd, 2022.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $55 on, Wednesday, August 10th, 2022


These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022
Contributing Sources